Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G SALOMON

Showing results (231-240 of 249) with videos related to

Pageof 25
Sort By:
The Journal of Biological Chemistry|July 10, 2002
Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36Eugene A Podrez, Eugenia Poliakov, Zhongzhou Shen, et al.
The Journal of Biological Chemistry|May 23, 1997
Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivoA D Watson, N Leitinger, M Navab, et al.
Cell Reports|February 21, 2020
Toll-like Receptor 2 Facilitates Oxidative Damage-Induced Retinal DegenerationKelly Mulfaul, Ema Ozaki, Nilisha Fernando, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 2009
[F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based studyT Steuber, T Schlomm, H Heinzer, et al.
Aktuelle Urologie|February 7, 2015
[Cancer control in focus insights and future perspectives for the focal treatment of prostate cancer]M Schostak, J Köllermann, B Hadaschik, et al.
The Journal of Biological Chemistry|July 30, 2002
A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesionsEugene A Podrez, Eugenia Poliakov, Zhongzhou Shen, et al.
Nature Medicine|August 28, 2007
Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotypeEugene A Podrez, Tatiana V Byzova, Maria Febbraio, et al.
Nature Medicine|April 10, 2012
NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen componentsSarah L Doyle, Matthew Campbell, Ema Ozaki, et al.
World Journal of Urology|May 6, 2016
Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stageJ J Wendler, R Ganzer, B Hadaschik, et al.
Der Urologe. Ausg. A|May 31, 2015
[Irreversible electroporation. Current value for focal treatment of prostate cancer]J J Wendler, R Ganzer, B Hadaschik, et al.
Pageof 25

Showing results (231-240 of 249) with videos related to

Sort By:
Pageof 25
The Journal of Biological Chemistry|July 10, 2002
Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36Eugene A Podrez, Eugenia Poliakov, Zhongzhou Shen, et al.
The Journal of Biological Chemistry|May 23, 1997
Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivoA D Watson, N Leitinger, M Navab, et al.
Cell Reports|February 21, 2020
Toll-like Receptor 2 Facilitates Oxidative Damage-Induced Retinal DegenerationKelly Mulfaul, Ema Ozaki, Nilisha Fernando, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 2009
[F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based studyT Steuber, T Schlomm, H Heinzer, et al.
Aktuelle Urologie|February 7, 2015
[Cancer control in focus insights and future perspectives for the focal treatment of prostate cancer]M Schostak, J Köllermann, B Hadaschik, et al.
The Journal of Biological Chemistry|July 30, 2002
A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesionsEugene A Podrez, Eugenia Poliakov, Zhongzhou Shen, et al.
Nature Medicine|August 28, 2007
Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotypeEugene A Podrez, Tatiana V Byzova, Maria Febbraio, et al.
Nature Medicine|April 10, 2012
NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen componentsSarah L Doyle, Matthew Campbell, Ema Ozaki, et al.
World Journal of Urology|May 6, 2016
Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stageJ J Wendler, R Ganzer, B Hadaschik, et al.
Der Urologe. Ausg. A|May 31, 2015
[Irreversible electroporation. Current value for focal treatment of prostate cancer]J J Wendler, R Ganzer, B Hadaschik, et al.
Pageof 25